EconomyNovo’s next-generation obesity drug shows 25% weight loss in women in late-stage analysis
Novo released new evidence that its experimental CagriSema injection may improve on the weight-loss results of its blockbuster GLP-1 obesity injection, Wegovy. A late-stage analysis showed 25% weight loss in women.
C
CNBC★★☆☆☆2026-10-20 12:50Original
Novo’s next-generation obesity drug shows 25% weight loss in women in late-stage analysis
Economy